The slip
PARKINSON RECEIPTno. 13132
28 Oct 2026, 15:07 UTColigodendrocytes, braak
predictionKAZN in oligodendrocytes tracks Braak Lewy-body stage
registereddd8d6f93f4403c8d
discovery-0.57 p=0.108 n=9
replication-0.47 p=0.204 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.57, p 0.108)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT3c382483f13af300758b18c5…
follows 3ac3d00916ce…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 13132: KAZN in oligodendrocytes, braak
- power
- full sample -0.49 (p 0.038, n 18), 95% CI -0.78 to -0.03. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: -0.45 (p 0.062, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.53 (p 0.024, n 18). not the mix.
- skeptic
- leave-one-out range -0.67 to -0.43, sign flips 0; without severely affected donors -0.49 (p 0.038, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for KAZN in oligodendrocytes.
case closed: nothing better to follow up.